This article is for information only. It is not investment advice, a solicitation, or a recommendation to buy or sell any security. Rare earth and junior mining stocks are speculative. Project studies can change. Offtake memoranda are not the same as funded plants. Readers should do their own work and, if needed, speak with a licensed adviser.
Rainbow Rare Earths Limited and Neo Performance Materials Inc. put a rare earth partnership on paper on 24 September 2026.
The paper is a memorandum of understanding.
It is not a construction permit.
It is not a bank package.
It is not first production.
That distinction is the whole story.
Rainbow is listed in London as RBW.
Neo is listed in Toronto as NEO, and in the United States as NOPMF on the OTCQX.
The project at the centre of the deal is Phalaborwa, in Limpopo province, South Africa.
Phalaborwa is not a classic hard-rock pit.
The feed is phosphogypsum.
The gypsum sits in two surface stacks.
The stacks are residue from old phosphoric acid work.
Rainbow says the rare earths in that gypsum are already in a chemically cracked form.
That claim is the project's main cost argument.
If it holds through a definitive study, Phalaborwa skips a lot of the work that kills other rare earth mines.
If it does not hold, the pretty numbers from 2024 will move.
Investors who want rare earth mining stocks on a watch list should start there.
Not with a slogan about China.
Not with a magnet headline.
With the difference between an MoU and a mill.
What the memorandum actually says
Neo will give technical support on solvent extraction circuit design.
That is the separation step.
Separation is where most rare earth projects stall.
Mining the ore is hard.
Turning a mixed concentrate into saleable oxides is harder.
Rainbow wants Neo's plant knowledge for that step.
The companies will also work toward offtake.
The MoU sketches two product streams.
First, separated neodymium-praseodymium oxide, or NdPr oxide, at more than 99 percent purity.
Neo would take 40 percent of Rainbow's annual NdPr oxide production from Phalaborwa.
Second, a mixed SEG+ carbonate.
SEG+ is a mid and heavy rare earth mix.
It can include samarium, europium, gadolinium, and heavier magnet metals such as dysprosium, terbium and yttrium.
Neo would take 65 percent of Rainbow's annual mixed SEG+ carbonate.
Pricing is meant to be arm's length.
The companies say they will use rare earth price indices.
That is better than a handshake price.
It is still not a published long-term contract.
The MoU also leaves a door open on the remaining 35 percent of SEG+ material.
The parties may look at toll treatment.
If that happens, separated dysprosium, terbium and yttrium would go back to Rainbow.
That clause matters.
Heavy rare earths are the scarce part of the magnet story.
A junior that keeps Dy, Tb and Y has a different product mix than a junior that sells only a mixed carbonate.
Test work starts in Estonia.
It then moves to an integrated pilot in Johannesburg.
Rainbow has already said a pre-feasibility study is targeted for the fourth quarter of 2026.
A definitive feasibility study is targeted for the first half of 2027.
First production is still targeted for 2028.
Those dates are targets.
They are not a schedule a lender has accepted.
Why Neo is the partner that changes the file
Most rare earth juniors can talk about a resource table.
Fewer can point to a working solvent extraction plant outside China.
Neo can.
Neo is a Canadian specialty materials company.
Its rare earth work in Europe is not a slide-deck idea.
The separation hub is Silmet, in Sillamäe, Estonia.
Silmet has long handled light rare earth separation.
In 2026 Neo also commissioned a small-scale heavy rare earth solvent extraction line there.
The company said that line produced separated terbium and dysprosium process solutions from mixed carbonate feedstock.
The magnet plant is in Narva, Estonia.
That plant has a Phase 1A nameplate near 2,000 tonnes a year of sintered rare earth magnets.
Neo has said commercial shipments to a tier-one electric-vehicle motor customer have started.
A later phase is designed to lift nameplate toward 5,000 tonnes a year.
Those plants do not make Phalaborwa a mine.
They do explain why Rainbow wanted Neo in the room.
An offtaker that already separates material and makes magnets has a reason to care about product spec.
A trading house can buy a tonne.
A magnet maker has to live with the chemistry.
That is the useful part of the MoU.
It ties Rainbow's gypsum project to a company that already sits further down the chain.
Neo is not Rainbow's only possible customer.
Neo is also not using Phalaborwa as its only feed idea.
Neo has other supply talks, including work with Carester in Europe.
Readers should treat this memorandum as one feed option for Neo, and one processing path for Rainbow.
It is not an exclusive marriage.
Phalaborwa is a gypsum project, not a new mountain
The resource is 35.0 million tonnes at 0.44 percent total rare earth oxide.
That figure is JORC.
The material sits in two phosphogypsum stacks.
Rainbow owns 85 percent of the project.
It holds an option to move to 100 percent.
The company's argument is simple.
A hard-rock rare earth mine has to drill, blast, haul, crush, grind, float and crack the ore.
Each of those steps costs money and time.
Each step also creates waste and permitting work.
Phalaborwa starts with residue that is already on surface.
Rainbow says the rare earths were chemically cracked when the original phosphate plant made phosphoric acid.
If that is true at commercial scale, the project avoids a large part of conventional mine capex.
That is why the company keeps calling Phalaborwa a chemical plant sitting on historic stacks, not a greenfield pit.
Investors should keep the language exact.
This is gypsum residue.
It is not a new discovery hole in hard rock.
The grade looks low next to some hard-rock deposits.
The company says the cracked state of the feed is what matters more than headline grade.
That claim has to survive the pre-feasibility study.
The resource table also lists thorium and uranium in parts per million.
Those numbers are low next to many hard-rock rare earth ores.
Low is not zero.
Residue projects still have to handle impurities, water, and the gypsum left after rare earths are pulled out.
A watch list file should include residue handling, not just magnet slogans.
The 2024 study is a baseline, not a bank case
Rainbow published an interim economic study in December 2024.
That study is the number set most people still quote.
Upfront capital was put at US$326.1 million.
The 2022 preliminary economic assessment had raw capex of US$295.5 million.
Rainbow said the 2024 figure was lower than the PEA capex after inflation was added.
Post-tax net present value at a 10 percent discount rate was about US$611 million.
The company website table rounds it to US$610.9 million.
Post-tax internal rate of return was 38 percent.
Project life was 16 years.
Average gypsum processing was 2.2 million tonnes a year.
Payback in that study was about two years.
Operating cost was put at US$40.83 per kilogram of magnet rare earth oxide.
That equated to US$12.91 per kilogram of total separated rare earth oxide when non-magnet rare earths were included, even though those extra rare earths were not given revenue in the model.
Rainbow, using Argus comparisons, called Phalaborwa the highest-margin rare earth project in development outside China.
That is the company's claim.
It is not an independent league table.
Readers should keep it labelled as such.
Production figures in company papers are not one clean number.
The 2024 interim study spoke of about 1,865 to 1,900 tonnes a year of separated magnet rare earth oxide.
That basket is neodymium, praseodymium, dysprosium and terbium together.
Later company decks put separated NdPr oxide near 1,800 to 1,817 tonnes a year.
Dysprosium and terbium were then shown at about 80 tonnes a year inside a SEG+ product.
Both ways of counting can be true at once.
They are not the same sentence.
A careful file says NdPr oxide is targeted around 1,800 tonnes a year, and total magnet rare earth oxide in the 2024 study was near 1,865 to 1,900 tonnes a year.
Those are study and target figures.
They are not a reserve statement and not a sales contract.
The 2024 model also used old PEA basket prices for comparison.
Rainbow has said that, at later spot prices, annual EBITDA would look different.
That is normal.
It is also a warning.
An NPV from December 2024 will not be the NPV in a 2026 pre-feasibility study if the flowsheet, capex or price deck changes.
The Neo work is one reason the flowsheet may change.
Rainbow has already moved the separation route toward industry-standard solvent extraction.
The 2024 study is therefore a baseline.
It is not the last word.
TechMet and the DFC option are support, not a closed cheque
Phalaborwa has political and financial backers that other juniors do not have.
TechMet Limited is a strategic shareholder in Rainbow, at about 12 percent in recent company materials.
TechMet also holds an option to invest US$50 million at project level.
Rainbow said that option is to be funded by the U.S. International Development Finance Corporation.
The stake that TechMet would take depends on the net present value in a definitive feasibility study.
Company disclosures have described a range, not a fixed percentage.
The money is meant to land around construction or a final investment decision.
It is not cash already sitting in a Phalaborwa plant account.
That is an important correction for anyone who heard “U.S. funding” and stopped reading.
A DFC-backed option is a signal.
It is not a full project finance package.
Rainbow still has to raise the rest of the equity and the debt.
Recent company commentary has sketched a capex band near US$325 million to US$350 million, with a large debt share and a remaining equity gap after the US$50 million option.
Those figures will move again when the pre-feasibility study is published.
Ecora holds a royalty interest in the project.
That is another claim on future cash, not a reason to ignore the asset.
It is a reason to model the asset as a project with partners, options and royalties, not as a clean 100 percent rainbow.
The calendar is the next fact that matters
Rainbow says the pre-feasibility study should arrive in the fourth quarter of 2026.
The definitive feasibility study is slated for the first half of 2027.
Construction has been discussed for 2027.
First production has been held at 2028.
That 2028 date has already lived through a slipped definitive study timetable.
The original public talk of a 2025 DFS did not hold.
Rainbow still says 2028 is the production target.
Miningmx and company releases after the Neo MoU repeated that target.
A slipped study and an unchanged first-pour date can both be true for a while.
They cannot both stay true forever.
The Neo test work is now part of the critical path.
If the Estonia work is slow, the Johannesburg pilot is slow.
If the pilot is slow, the pre-feasibility study is late.
If the pre-feasibility study is late, the definitive study is late.
If the definitive study is late, 2028 becomes a hope, not a plan.
That is the watch-list test for the next two quarters.
Not the press-release language.
The date on the next study.
What “what's next for Phalaborwa” should mean
The next useful events are boring.
They are also the only events that change value.
First, long-form agreements.
The MoU has to become contracts with volumes, specs, penalties and term.
Until that happens, the 40 percent and 65 percent splits are a framework.
Second, test results.
Neo has to show that Phalaborwa material behaves in a solvent extraction circuit the way the companies expect.
Purity targets above 99 percent for NdPr are easy to print.
They are harder to hold at plant scale, day after day.
Third, the pre-feasibility study.
That document should restated capex, opex, recoveries and product mix after the Neo work.
If the 2024 NPV only survives by keeping 2024 prices and 2024 costs, the study is a brochure.
If the new study shows a still-workable margin after current costs, the file gets more serious.
Fourth, product strategy on heavies.
Will Rainbow sell most SEG+ as a mixed carbonate?
Or will tolling return separated dysprosium, terbium and yttrium?
Those two outcomes are not the same business.
Fifth, funding.
The TechMet option, the residual equity gap, and debt capacity all sit behind the studies.
A rare earth plant is not built with a memorandum and a conference badge.
Sixth, South African execution.
Limpopo is an established mining district.
That helps with power, skills and access.
It does not remove permitting, residue handling, or local operating risk.
A Canadian reader should keep Neo in view as the listed midstream name.
Rainbow remains a London-listed developer.
The two stocks are not substitutes.
One is a materials company with plants.
One is a project company with gypsum stacks and a study calendar.
The supply-chain backdrop, without the sermon
China still dominates rare earth separation and magnet-metal making.
That fact is why Western offtake stories get written.
It is also why they get over-written.
A memorandum with a Canadian processor in Estonia does not break a Chinese monopoly.
It adds one more possible non-Chinese tonne, years from now, if the plant is built.
Magnet demand sits in electric vehicles, wind turbines, robotics, electronics and defence.
NdPr is the bulk magnet feed.
Dysprosium and terbium help magnets hold strength at heat.
Yttrium has its own industrial uses.
Phalaborwa's pitch is that one gypsum site can offer both light and heavy streams.
That mix is rare among Western projects.
Rarity is not the same as delivery.
The world does not pay for a resource table.
It pays for on-spec oxide and carbonate, shipped on time.
That is why the Neo partnership is interesting.
And that is why it is still incomplete.
How a watch-list investor should hold the idea
Critical mineral stocks reward patience and punish slogans.
Phalaborwa is a case study in that rule.
The surface gypsum argument is real enough to study.
The 2024 economics are real enough to use as a starting grid.
The Neo memorandum is real enough to put the project on a short list of names that now have a midstream partner.
None of that makes the shares a purchase order.
Position size, if any, belongs in the speculative sleeve.
The file should assume delay.
The file should assume capex inflation.
The file should assume that offtake percentages move when lawyers finish the long-form text.
The file should assume that 2028 is a target that can slip.
The file should also admit the other side.
If the studies hold the low-cost gypsum case, and if Neo's plants need feed, Phalaborwa is one of the few Western rare earth stories that does not start with a new open pit.
That is the opportunity.
It is conditional.
Canadian rare earth stocks and TSX rare earth names often get bundled into one search.
Neo is the processing and magnet name in that basket.
Rainbow is the Phalaborwa developer.
Other Canadian and TSX-listed rare earth names are not this deal.
Do not blur them.
Rare earth mining stocks, rare earth processing stories and magnet stories pay for different risks.
This memorandum sits in the middle of those three files.
Treat it that way.
Risks that should stay on the first page
The MoU can lapse.
Test work can fail or run long.
Solvent extraction can cost more than the 2024 study implied.
Rare earth prices can stay weak while capex rises.
South African operating and political risk does not vanish because a Canadian processor joined the file.
Currency moves can hit both London and Toronto listings.
Dilution is normal in developers.
A US$50 million option is not the same as a built plant.
China can add supply or change export rules faster than a gypsum project can reach first pour.
Magnet demand can disappoint if electric-vehicle growth slows.
Any one of those points can overpower a good press release.
That is why this article keeps repeating the same sentence.
Watch the studies.
Do not buy the headline.
People also asked
What is next for Rainbow Rare Earths Phalaborwa?
The next items are Estonia test work, a Johannesburg pilot, a pre-feasibility study in the fourth quarter of 2026, and then a push toward a definitive study in the first half of 2027. First production is still targeted for 2028. Those dates remain company targets.
What does the Neo partnership mean for Rainbow Rare Earths?
It gives Rainbow a midstream partner with solvent extraction plants at Silmet in Sillamäe and magnet capacity at Narva. The MoU sketches offtake of 40 percent of NdPr oxide and 65 percent of mixed SEG+ carbonate. It does not fund construction and it is not a final contract.
Is Phalaborwa a producing rare earth mine?
No. It is a development project on phosphogypsum stacks. The 2024 interim study is an economic case, not an operating result.
Should investors buy Rainbow or Neo on this news?
This article does not recommend a purchase. The memorandum is a reason to research both files. It is not a reason to treat either stock as a completed supply-chain solution.
Rainbow Rare Earths now has a named technical and offtake partner for Phalaborwa.
That is progress.
Progress in rare earths is measured in signed contracts, locked flowsheets and funded concrete.
The memorandum is the start of that measurement.
It is not the end of it.
For readers who follow rare earth mining stocks, Canadian rare earth stocks, rare earth processing, NdPr oxide, SEG+ carbonate, and critical mineral supply chains, Phalaborwa belongs on the watch list for the next study cycle.
It does not belong in a paid-for victory lap.
The gypsum is already on the ground.
The plant is not.
That is what's next.
Disclaimer: Canadian Mining Report and its writers are not responsible for any investment decisions made from this article. Securities mentioned are for illustration and research context only. Rainbow Rare Earths Limited and Neo Performance Materials Inc. are publicly traded companies. Project economics cited here come from company studies and announcements and can change. Past performance is not a guide to future results. This is not a buy, sell or hold recommendation.